A Retrospective Study for Relapse Rate According to the Discontinuance of Para-aminosalicylic acid(PAS) after Bacteriological Conversion during the Course of Chemotherapy for Multidrug-Resistant Tuberculosis(MDR-TB)

Seung-Kyu PARK; Byoung-Ju KIM; Dong-Ohk SHIN; Byung-Yool JUN.
Tuberculosis and Respiratory Diseases ; : 180-186, 2006.
Artículo en Ko | WPRIM | ID: wpr-69161

Documentos relacionados

  1. More Tailored Approaches to Tuberculosis Treatment and Prevention.
  2. Transmission of multidrug-resistant tuberculosis within family households by DTM-PCR and MIRU-VNTR genotyping.
  3. Determinants of catastrophic costs among households affected by multi-drug resistant tuberculosis in Ho Chi Minh City, Viet Nam: a prospective cohort study.
  4. [Expert consensus on clinical application of delamanid].
  5. Interventions to Improve Adherence to Medication on Multidrug-Resistant Tuberculosis Patients: A Scoping Review.
  6. Decentralized Care for Rifampin-Resistant Tuberculosis, Western Cape, South Africa.
  7. Prothionamide Dose Optimization Using Population Pharmacokinetics for Multidrug-Resistant Tuberculosis Patients.
  8. The heme oxygenase-1 metalloporphyrin inhibitor stannsoporfin enhances the bactericidal activity of a novel regimen for multidrug-resistant tuberculosis in a murine model.
  9. Global burden of MDR-TB and XDR-TB attributable to high fasting plasma glucose from 1990 to 2019: a retrospective analysis based on the global burden of disease study 2019.
  10. Pediatric multi-drug-resistant tuberculosis in Germany - diagnostic and therapeutic challenges of an "orphan disease".